Impact of brief cognitive behavioral treatment for insomnia on health care utilization and costs

Journal of Clinical Sleep Medicine

Volumn 10, Issue 2, 2014, Pages 127-135

  McCrae, Christina S ^a   Bramoweth, Adam D ^b   Williams, Jacob ^a   Roth, Alicia ^a   Mosti, Caterina ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Brief cognitive behavioral treatment; Costs; Health care utilization; Insomnia; Medication; Physician visits

Indexed keywords

BRIEF COGNITIVE BEHAVIORAL TREATMENT; COSTS; HEALTH CARE UTILIZATION; INSOMNIA; MEDICATION; PHYSICIAN VISITS;

COGNITIVE THERAPY; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 84894281474     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.3436     Document Type: Article

References (53)

1. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep 1999;22 Suppl 2:S347-53. (Pubitemid 29293494)
2. Martin S, Aikens J, Chervin R. Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia. Sleep Med Rev 2004;8:63-72. (Pubitemid 38313381)
3. Stoller M. Economic effects of insomnia. Clin Ther 1994;16:873-97.
4. Daley M, Morin CM, LeBlanc M, Gregoire JP, Savard J. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep 2009;32:55-64.
5. Ozminkowski RJ, Wang S, Walsh JK. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 2007;30:263-73. (Pubitemid 46494401)
6. Sarsour K, Kalsekar A, Swindle R, Foley K, Walsh JK. The association between insomnia severity and healthcare and productivity costs in a health plan sample. Sleep 2011;34:443-50.
7. Leger D, Guilleminault C, Bader G, Levy E, Paillard M. Medical and socio-professional impact of insomnia. Sleep 2002;25:625-9. (Pubitemid 34977501)
8. Roy AN, Smith M. Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization. Sleep Med 2010;11:462-9.
9. Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep 2007;30:213-8.
10. Asche CV, Joish VN, Camacho F, Drake CL. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder. Curr Med Res Opin 2010;26:1843-53.
11. Bramoweth AD, Taylor DJ. Chronic insomnia and health care utilization in young adults. Behav Sleep Med 2012;10:106-21.
12. Tian H, Abouzaid S, Gabriel S, Kahler KH, Kim E. Resource utilization and costs associated with insomnia treatment in patients with major depressive disorder. Prim Care Companion CNS Disord 2012;14(5).
13. Rieu-Werden ML, Sutton-Skinner KM, Romeo SA, Fromson JA, Birnbaum RJ. Underutilization of nonpharmacologic interventions for insomnia by healthcare providers. In. New Orleans, LA: Annual Meeting of the American Psychiatric Association, 2010.
14. Jhaveri M, Seal B, Pollack M, Wertz D. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States. Curr Med Res Opin 2007;23:1431-43. (Pubitemid 46998451)
15. Snedecor SJ, Botteman MF, Bojke C, Schaefer K, Barry N, Pickard AS. Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia. Sleep 2009;32:817-24.
16. Uchiyama M, Hamamura M, Kuwano T, Nishiyama H, Nagata H, Uchimura N. Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia. Sleep Med 2011;12:119-26.
17. Hajak G, Hedner J, Eglin M, et al. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients. Sleep Med 2009;10:705-12.
18. Krystal AD, Durrence HH, Scharf M, et al. Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia. Sleep 2010;33:1553-61.
19. Krystal AD, Lankford A, Durrence HH, et al. Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. Sleep 2011;34:1433-42.
20. Ancoli-Israel S, Krystal AD, McCall WV, et al. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. Sleep 2010;33:225-34.
21. Edinger JD, Wohlgemuth W, AD K, Rice J. Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial. Arch Intern Med 2005;165:2527-35. (Pubitemid 41720016)
22. Currie S, Wilson K, Pontefract A, deLaplante L. Cognitive-behavioral treatment of insomnia secondary to chronic pain. J Consult Clin Psychol 2000;68:407-16.
23. Quesnel C, Savard J, Simard S, Ivers H, Morin C. Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. J Consult Clin Psychol 2003;71:189-200. (Pubitemid 36157310)
24. Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002;159:5-11. (Pubitemid 41070720)
25. Lichstein KL, Morin CM. Treatment of Late-Life Insomnia. Thousand Oaks, CA: Sage, 2010.
26. Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA 2001;285:1856-64. (Pubitemid 32289153)
27. Dolan DC, Taylor DJ, Bramoweth AD, Rosenthal LD. Cognitive-behavioral therapy of insomnia: a clinical case series study of patients with co-morbid disorders and using hypnotic medications. Behav Res Ther 2010;48:321-7.
28. Manber R, Carney C, Edinger J, et al. Dissemination of CBTI to the non-sleep specialist: protocol development and training issues. J Clin Sleep Med 2012;8:209-18.
29. McCrae CS, Dautovich ND, Dzierzewski JM. Short-term and group interventions for insomnia. In: Sateia M, Buysse D, eds. Insomnia: diagnosis and treatment. New York: Informa Healthcare, 2010.
30. Buysse DJ, Germain A, Moul DE, et al. Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med 2011;171:887-95.
31. Edinger JD, Sampson WS. A primary care "friendly" cognitive behavioral insomnia therapy. Sleep 2003;26:177-82. (Pubitemid 39610694)
32. McCrae CS, McGovern R, Lukefahr R, Stripling AM. Research Evaluating Brief Behavioral Sleep Treatments for Rural Elderly (RESTORE): a preliminary examination of effectiveness. Am J Geriatr Psychiatry 2007;15:979-82.
33. American Academy of Sleep Medicine. International Classification of Sleep Disorders; 2nd ed: Diagnostic and Coding Manual. Westchester, IL: American Academy of Sleep Medicine, 2005.
34. American Psychatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision. Washington, DC: American Psychatric Association, 2000.
35. Edinger JD, Bonnet MH, Bootzin RR, et al. Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep 2004;27:1567-96. (Pubitemid 40041627)
36. Taylor DJ, Lichstein KL, Durrence HH, Reidel BW, Bush AJ. Epidemiology of insomnia, depression, and anxiety. Sleep 2005;28:1457-64. (Pubitemid 41572796)
37. Clark DO, Von Korff M, Saunders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Med Care 1995;33:783-95.
38. Riedel BW. Sleep hygiene In: Lichstein KL, Morin CM, eds. Treatment of late-life insomnia. Thousand Oaks, CA: Sage, 2000.
39. Bootzin R. A stimulus control treatment for insomnia. Paper presented at: 80th Annual Convention of the American Psychological Association 1972.
40. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008;4:487-504.
41. Beck AT, Steer RA, Brown G. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996.
42. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1983.
43. Blair RC, Higgins JJ. A comparison of the power of the paired sample t-test to that of Wilcoxon's signed-ranks test under various population shapes. Psychol Bull 1985;97:119-28.
44. Cohen J. A power primer. Psychol Bull 1992;112:155-9.
45. O'Keeffe KM, Gander PH, Scott WG, Scott HM. Insomnia treatment in New Zealand. N Z Med J 2012;125:46-59.
46. Rosekind MR, Gregory KB, Mallis MM, Brandt SL, Seal B, Lerner D. The cost of poor sleep: workplace productivity loss and associated costs. J Occup Environ Med 2010;52:91-8.
47. Germain A, Moul D, Franzen P, et al. Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. J Clin Sleep Med 2006;2:403-6. (Pubitemid 44763798)
48. Troxel WM, Germain A, Buysse DJ. Clinical management of insomnia with brief behavioral treatment (BBTI). Behav Sleep Med 2012;10:266-79.
49. McCrae CS, Lichstein KL. Secondary insomnia: diagnostic challenges and intervention opportunities. Sleep Med Rev 2001;5:47-61. (Pubitemid 32666497)
50. Shahly V, Berglund PA, Coulouvrat C, et al. The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey. Arch Gen Psychiatry 2012;69:1054-63.
51. Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med 2011;7:57-68.
52. Cheung A, Dewa C, Michalak EE, et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depression Res Treat 2012;2012:628434.
53. Konig HH, Leicht H, Bickel H, et al. Effects of multiple chronic conditions on health care costs: an analysis based on an advanced tree-based regression model. BMC Health Serv Res 2013;13:219.